. . . . . . . . . . . . "[To address the need for new treatments, we have undertaken a chimeric antigen receptor (CAR) `designer T cell` (dTc) immunotherapeutic strategy by exploiting interleukin (IL)13 receptor α-2 (IL13Rα2) as a GBM-selective target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:38:43+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .